Drug
Eladocagene Exuparvovec
Eladocagene Exuparvovec: highest development phase Phase 2, developed by PTC Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- PTC Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Eladocagene Exuparvovec NCT04903288 | Phase 2 | AADC Deficiency |
Latest
No recent events.
Follow Eladocagene Exuparvovec on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.